Preliminary research presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions 2026 suggests a potential link between the oral bacterium Porphyromonas gingivalis and the development of calcific aortic valve stenosis (CAVS). The study, which utilized both human heart tissue analysis and mouse models, indicates that this pathogen may drive inflammation and calcium accumulation in the aortic valve, offering a new target for future preventive cardiovascular research.
The Potential Biological Link Between Gum Disease and CAVS
Calcific aortic valve stenosis is a progressive heart condition where the aortic valve thickens and calcifies, obstructing blood flow from the heart to the rest of the body. According to the American Heart Association, common symptoms include fatigue, chest pain, shortness of breath, and, in severe cases, heart failure or premature death. Currently, there are no pharmacological treatments to slow or reverse the disease, leaving surgical valve replacement as the standard of care for severe cases.
Researchers from the State Key Laboratory of Cardiovascular Disease at Fuwai Hospital in Beijing investigated whether P. gingivalis—a primary driver of periodontal disease—contributes to this process. By analyzing heart valve tissue from patients undergoing valve replacement surgery, the team identified a significant presence of P. gingivalis in calcified valves compared to non-calcified control samples.
Insights from Animal Models
To determine if the bacteria directly cause valve damage, the research team conducted experiments on mice exposed to either live or heat-inactivated P. gingivalis. The study found that repeated exposure to the live bacteria led to bacterial accumulation in the aortic valves, increased calcium deposits, and the development of symptoms consistent with aortic stenosis.
The mechanism appears to involve the interleukin-1 beta (IL-1β) inflammatory pathway. Researchers observed that P. gingivalis activated this protein, which is produced by immune cells to promote inflammation. When the team genetically deleted IL-1β in the mice, valve calcification and disease symptoms were significantly reduced, even when the bacteria were present. Furthermore, preventive antibiotic treatment in mice successfully mitigated the calcification effects.
The Role of Oral Health in Cardiovascular Wellness
While these findings highlight a potential biological mechanism, the researchers emphasize that the data are preliminary. Because the work was presented as a scientific meeting abstract, it has not yet undergone full peer review or been published in a medical journal.
"The key message is simple: take good care of your oral health," said co-lead author Chenyang Li, M.D., a Ph.D. candidate at the National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College.
Eduardo Sanchez, M.D., M.P.H., FAHA, chief medical officer for prevention at the American Heart Association, noted that the study reinforces the connection between oral and systemic health. "For many people, regular visits to the dentist are their only connection to the healthcare system," Sanchez said. "That makes dental professionals important partners in spotting health conditions, including periodontal disease, early."
The research team has initiated a clinical study in humans to further investigate whether treating periodontal disease can serve as a strategy to prevent or slow the progression of CAVS. The American Heart Association’s Healthy Smiles, Healthy Hearts™ initiative continues to provide educational resources to help dental and medical professionals coordinate care to improve both oral and cardiovascular outcomes.
Related reading